Atlas Trials

Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes

Clinical trial NCT03336528 · COMPLETED

Trial details

NCT number
NCT03336528
Sponsor
Emory University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2018-01-02
Primary completion
2021-03-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.